← Back to Clinical Trials
Recruiting NCT05426551

Validation of the Dual-isotope Method for Measuring Ileal Protein Digestibility

Trial Parameters

Condition Healthy
Sponsor Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement
Study Type INTERVENTIONAL
Phase N/A
Enrollment 36
Sex ALL
Min Age 18 Years
Max Age 45 Years
Start Date 2022-10-23
Completion 2024-05-30
Interventions
Dual isotope method

Brief Summary

The dual isotope method has been recently developed and used to evaluate indispensable amino acid (IAA) digestibility of various protein food such as legumes, eggs and chicken meat in healthy adults and children. The dual isotope method is an indirect method based on the measurement in plasma of absorbed IAA from a deuterium (2H) intrinsically labeled test protein compared against the same IAA of a carbon 13 (13C) intrinsically labeled standard protein of known digestibility or crystalline amino acids (AA) of theoretical 100% digestibility. However, digestibility data estimated with the dual isotope method have not been directly compared with ileal IAA digestibility directly determined through ileal digesta sampling. The goal of this study is to assess the IAA digestibility of intrinsically 2H-hen's egg in healthy volunteers using both indirect and direct methods.

Eligibility Criteria

Inclusion Criteria: * 18\<BMI\<30 * Healthy * Insured under the French social security system * For women: use of birth control * Signed informed consent Exclusion Criteria: * Any dietary allergy * Latex allergy * Positive serology to HIV, hepatite C virus antibody, hepatite B virus surface antigen and core antibodies * Gluten intolerance * Anemia * Use of drugs * High consumption of alcohol * Hypertension, diabetes, digestive disease, hepatic or renal disease, severe cardiac disease * Pregnancy * High sport practicing (\>7h/wk) * Blood donation in the 3 months prior to the study * Participation in a clinical study in the 3 months prior to the study * No signed informed consent

Related Trials